6846.TWO Greenyn Biotechnology Co., Ltd

Healthcare Biotechnology Taiwan OTC Exchange
49.00 TWD
Close of Nov 6, 2026
48.00 73.41
Market cap
TWD 1.33B
P/E
12.2x
P/B
1.63x
ROE
10.0%
Dividend yield
7.32%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6846.TWO undervalued?

Graham number
Price49.00
Graham value52.25
Discount6.2%

6846.TWO trades 6.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Greenyn Biotechnology Co., Ltd fundamental analysis

No fundamental analysis for Greenyn Biotechnology Co., Ltd yet.

Greenyn Biotechnology Co., Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care se…

Full company profile